U.S. Physical Therapy, Inc. (USPH): financial analysis & fundamentals

Health Care · price $79.10 · market cap —

In short — U.S. Physical Therapy, Inc. trades at —× earnings (P/E), —× expected earnings, for a PEG of — and a net margin of —. Revenue growth —. Quick verdict: valuation to review.

📈 See the interactive version (live chart) →

🔗 Related pages on U.S. Physical Therapy, Inc. — Are analysts right? · If I had invested

Valuation & profitability

Metric	Value	What it means
P/E (price / earnings)	—	The higher, the more growth the market expects.
Forward P/E	—	On next year's expected earnings. Lower than current P/E = rising earnings.
PEG (P/E ÷ growth)	—	Below 1 = cheap given growth; above 2 = expensive.
Net margin	—	Share of revenue that ends up as profit.
Revenue growth	—	Pace of revenue growth.
Price-to-book	—	Price relative to book value.
Market cap	—	Total market value of the company.
Dividend yield	—	No dividend currently.

📊 Open the interactive U.S. Physical Therapy, Inc. page (charts, live news) →

Frequently asked questions

Is U.S. Physical Therapy, Inc. stock expensive?

U.S. Physical Therapy, Inc. has a P/E of — (forward P/E —) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.

What is U.S. Physical Therapy, Inc.'s net margin?

U.S. Physical Therapy, Inc.'s net margin is about — — the share of revenue that ends up as net profit.

What is U.S. Physical Therapy, Inc.'s revenue?

U.S. Physical Therapy, Inc.'s income statement is detailed on this page.

What is U.S. Physical Therapy, Inc.'s market cap?

U.S. Physical Therapy, Inc. (USPH) has a market cap of about —.

Does U.S. Physical Therapy, Inc. pay a dividend?

No, U.S. Physical Therapy, Inc. does not currently pay a dividend (it reinvests earnings).

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
💬 AI assistant: ask anything about any stock, with the numbers
📊 Portfolio tracking + 🔔 price alerts by email

Explore JPI Invest for free → How it works: the method →

⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.